Radiolysis of radioimmunoconjugates. Reduction in antigen-binding ability by α-particle radiation
- 1 October 1995
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 36 (10) , 1009-1018
- https://doi.org/10.1002/jlcr.2580361012
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibodyBritish Journal of Cancer, 1994
- Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumorsCancer, 1994
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- The Radiobiology of Targeted RadiotherapyInternational Journal of Radiation Biology, 1990
- Resident's essay award: Alpha particle radio-immunotherapy: Animal models and clinical prospectsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Synthesis of radioiodinated N-succinimidyl iodobenzoate: Optimization for use in antibody labellingInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1989
- Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenograftsBritish Journal of Cancer, 1987
- New monoclonal antibodies specific for human sarcomasInternational Journal of Cancer, 1986
- Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.Proceedings of the National Academy of Sciences, 1986